Full Breakdown
Government Push for Hospital Price Transparency in India
By Drooid · · How we work
Directive Overview
On October 12, 2026, Union Health Secretary Punya Salila Srivastava sent a letter to chief secretaries of all Indian states and union territories urging hospitals and clinical establishments to prominently display rates for each service in both the local language and English, including package rates for foreign patients on medical or Ayush visas.
Legal Framework & Implementation
The instruction cites the Clinical Establishments (Registration and Regulation) Act, 2010 and the Clinical Establishments (Central Government) Rules, 2012. Section 9 of the Rules requires visible posting of service charges. Where the central Act does not apply, states are asked to use their own regulations, many of which already contain similar disclosure provisions.
Rationale Stated by the Ministry
The Ministry says price disclosure will help patients understand likely treatment costs, make informed decisions, and plan expenditure. It expects transparency to reduce billing disputes, minimise confusion, and build trust. For international patients, visible package rates should allow cost comparison before seeking treatment, reinforcing India’s reputation as a medical destination.
Official Statements & Responses
The Union Health Secretary emphasized a review of compliance with existing provisions and asked state authorities to issue advisories to clinical establishments. The letter stresses that the conspicuous display of rates is intended to make pricing information “clearly visible and easily accessible” to patients and attendants.
Data & Statistics
- A Business Standard report highlighted a nearly 1,000 % divergence between price-to-retailer and maximum retail price for drugs and consumables in several states.
- The Supreme Court bench of Justices Vikram Nath and Sandeep Mehta recently examined high mark-ups on essential medicines, including cancer drugs, and asked the Centre to consider a uniform trade-margin cap.
Timeline
- October 12, 2026 – Secretary’s letter demanding price-display compliance.
- September 15, 2026 – Mint reported steep profit mark-ups on medical consumables based on the Maharashtra FDA inquiry.
- May 14, 2026 – Scheduled report on the government’s enforcement plan for pricing transparency.
Conflicting Reports & Gaps
While the Ministry presents disclosure as a solution to billing disputes, activists note that treatment costs vary widely with investigations, complications, length of stay, and medication needs. No data have been released on state-level compliance rates or on the effectiveness of displayed rates in reducing patient grievances.
Verbatim Quotes
- “I would request you to kindly advise the authorities concerned to review compliance with applicable provisions relating to display of rates and take appropriate measures to ensure their effective implementation,” — Punya Salila Srivastava
- “This would enable international patients to make informed choices, help minimise pricing and billing-related grievances and further strengthen India's position as a trusted destination for medical and Ayush care,” — Punya Salila Srivastava